California
Association
for
Medical Laboratory Technology
Distance Learning Program
|
Hemoglobin
A1c Testing of Patients with Hemoglobinopathies Course
Number: DL-973 © California Association
for Medical Laboratory Technology. CAMLT is approved by the California Department
of Health Services as a 1895 Mowry Ave, Suite 112 Notification of Distance Learning Deadline |
| This course is configured to be completed on-line. You can register
for the course, submit secure payment using a credit card via PayPal,
take the quiz on-line and receive your graded score.
If you pass, your certificate will be mailed to you from
the CAMLT office. If you fail, you must submit new payment and obtain a new PayPal receipt each time you take the test. A certificate will be issued only if you have paid for re-taking the course and you pass the test. If you want to submit your registration and quiz via fax or mail you should print the Adobe Acrobat version of the course which includes the required Registration/Quiz form. |
| Links to: On-line REGISTRATION, PAYMENT and QUIZ Printable Acrobat version of this course * Other Distance Learning Courses |
|
Hemoglobin A1c Testing of Patients with Hemoglobinopathies
Completion of this course
requires downloading the Acrobat Version (link above).
You may then print a copy or view the downloaded file on your computer
to see the course material.
Only the Introduction and Objectives appear below.
INTRODUCTION
Hemoglobin A1c is the most useful single index of blood glucose control available
to diabetics. Increased HbA1c is closely linked to risk of long-term microvascular
diabetic complications (1). HbA1c is measured in the laboratory using a variety
of methods. The presence of hemoglobinopathies in a patient presents a confounder
to HbA1c testing, yielding erroneous laboratory test results. Beginning with
a description of HbA1c and its relationship to blood glucose followed by methods
of testing for HbA1c in the laboratory, this course focuses on the problematic
aspects of testing for HbA1c in a patient with a hemoglobinopathy using each
of these methods. General conclusions, limitations, and recommendations for
testing are given.
OBJECTIVES:
On completion of this course the participant will be able to: